Newsroom

SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq : ONC ; HKEX : 06160 ; SSE : 688235), une société internationale spécialisée en oncologie, a annoncé aujourd’hui les premiers résultats positifs de la deuxième analyse intermédiaire (IA2) de l’essai de phase III HERIZON-GEA-01 évaluant le ZIIHERA® (zanidatamab), en association avec une chimiothérapie, avec ou sans TEVIMBRA® en tant que traitement de première intention de l’adénocarcinome gastro-œsophagien (GEA) HER2+ localement a...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Hyliion Holdings Corp. (“Hyliion” or the “Company”) (NYSE: HYLN) on behalf of investors concerning the Company’s possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON HYLIION HOLDINGS CORP. (HYLN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.What Is The Investigation About?On June 23, 2026, Pelican Way Research issued a report entitled “...

SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today announced that its Tanager-2 satellite and the 18 SuperDove satellites of Flock 4J have arrived at Vandenberg Space Force Base in California ahead of their launch aboard the upcoming Transporter-18 rideshare mission with SpaceX. Building on the operational success of Planet's recent launches, this multi-constellation shipment marks a significant milestone in the...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced the issuance of inducement grants to three newly hired non-executive employees consisting of options to purchase an aggregate of 88,900 common shares of the Company (the "Options") with effective grant dates of August 31, 20...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will participate in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference (Boston) | Fireside Chat September 8, 2026 (2:15 p.m. ET) Citi's 2026 Biopharma Back to School Conference (New York) | Fireside Chat September 9...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the following investor conferences:Wells Fargo Healthcare Conference on Thursday, September 10, 2026, in Boston, MAH.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 15, 2026, in New York, NYAbout Delcath Systems, Inc., HEPZATO KIT and CHEMO...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Brown-Forman Corporation (NYSE: BFA, BFB) announced today that President and Chief Executive Officer Lawson Whiting and Executive Vice President and Chief Financial Officer Jim Peters will participate in a “fireside chat” during the Barclays Global Consumer Conference in Boston on Wednesday, September 9, 2026. The event will begin at approximately 12:45 p.m. (EDT) and will be available as a webcast on the Brown-Forman website at brown-forman.com on the Investors...

SAN FRANCISCO--(BUSINESS WIRE)--Chime® (Nasdaq: CHYM) today announced an expanded commitment to Trump Accounts that will help all Chime employees invest in their children’s futures and more Americans take advantage of this new wealth-building opportunity. The announcement builds on Chime’s broader nationwide efforts to drive awareness and participation in the program. Chime was among the first companies to commit to matching the U.S. Treasury’s $1,000 seed contribution dollar-for-dollar for eli...

LOS ANGELES--(BUSINESS WIRE)--INV Investors Have Opportunity to Lead Innventure, Inc. Securities Fraud Lawsuit with SBS Law...